Jun 4, 2026 08:03AM

Jun 4, 2026 08:00AM

Mar 12, 2026 08:32AM

Mar 12, 2026 08:30AM

Mar 10, 2026 08:31AM

Mar 10, 2026 08:30AM

Dec 5, 2025 04:40PM Celularity receives FDA warning letter over Interfyl marketing claims

Oct 14, 2025 08:45AM

Oct 14, 2025 08:45AM

Jul 9, 2025 08:30AM

Jul 1, 2025 08:30AM

May 9, 2025 09:15AM

Feb 25, 2025 08:00AM

Oct 22, 2024 08:31AM Celularity (CELU) Provides Corporate Update

Oct 22, 2024 08:30AM

Mar 20, 2024 09:15AM

Mar 20, 2024 09:15AM

Feb 1, 2024 09:00AM

Oct 18, 2023 09:03AM

Apr 12, 2023 09:00AM

Apr 3, 2023 09:05AM Celularity (CELU) Receives FDA Preliminary Assessment For Celularity’s Investigational Fuse Bone Void Filler To Be Regulated As A Device By FDA’s Center For Devices And Radiological Health

Apr 3, 2023 09:00AM

Feb 2, 2023 07:53AM

Feb 1, 2023 04:06PM

Feb 1, 2023 04:05PM

Jan 26, 2023 04:17PM

Jan 4, 2023 04:10PM

Nov 30, 2022 09:55AM Celularity CEO Robert J. Hariri, M.D., Ph.D., Addresses FII Conference on “The Science and Technology for Extending Healthy Human Lifespan”

Nov 10, 2022 04:10PM

Oct 3, 2022 08:01AM

Oct 3, 2022 08:00AM

Sep 26, 2022 08:01AM

Sep 26, 2022 08:00AM

Aug 9, 2022 04:10PM

Jul 27, 2022 08:00AM Celularity Announces Treatment of First Patient in Phase 1/2a Clinical Trial for NK Cell Therapy CYNK-101, in Development for the First-Line Treatment of Advanced HER2 Positive Gastric and Gastroesoph

May 16, 2022 04:10PM

Mar 31, 2022 04:05PM

Feb 15, 2022 04:25PM

Feb 15, 2022 04:05PM

Jan 18, 2022 08:00AM

Dec 27, 2021 09:24AM

Dec 27, 2021 09:15AM Celularity (CELU) Stock Gains 6% on FDA Fast Track Endorsement for CYNK-001

Dec 27, 2021 08:01AM

Dec 27, 2021 08:00AM

Nov 29, 2021 08:03AM

Nov 29, 2021 08:00AM

Sep 15, 2021 08:00AM

Aug 16, 2021 05:15PM

Jul 16, 2021 08:00AM Celularity Closes Merger with GX Acquisition Corp and Provides Corporate Update

323,712 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All